Tangji Medical's Weight Loss Medical Stent Is Designed For Metabolic Diseases

Tangji Medical is a national high-tech enterprise and a specialized, refined, distinctive and innovative enterprise in Zhejiang Province, dedicated to metabolic diseases and committed to building an innovative platform for digestive tract interventional therapy and related medical equipment, disease management and solutions. After years of unremitting efforts, the company has successfully developed a number of new medical technologies for metabolic diseases such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease. The "Gastric Bypass Stent System", which was first developed by the company, is the world's first and currently the only medical device in China for intestinal interventional treatment of metabolic diseases. It was approved as a national Class III innovative medical device (the world's first certificate) on January 17, 2024, and obtained the production license on January 30, 2024. Subsequently, it was recommended in the "Expert Consensus on Digestive Endoscopy Diagnosis and Treatment of Obesity in China". In March 2024, it obtained the National Medical Insurance consumables Code, and on October 2, 2024, it was granted the "Breakthrough Medical Device Designation" by the US FDA. This landmark product will provide more convenient, safe and effective treatment options for many patients with metabolic diseases. Tangji Medical is dedicated to the accumulation of R&D capabilities. It has currently established multiple technical platforms and possesses a complete R&D, quality, production and supply chain system, and has passed the ISO13485 certification. As of October 2024, the company has filed over 110 patents worldwide, and several of its products are undergoing clinical trials at different stages in more than 100 renowned hospitals. Tangji Medical will continue to uphold the concept of "innovation-driven and doctor-patient centered", constantly explore new fields of interventional treatment for metabolic diseases, and create a better life for patients around the world.